La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Apex Healthcare Berhad Gestione

Gestione criteri di controllo 4/4

Apex Healthcare Berhad's Il CEO è Kirk Kee, nominato in May2010, e ha un mandato di 14.25 anni. la retribuzione annua totale è MYR 283.27K, composta da 18.3% di stipendio e 81.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.17% delle azioni della società, per un valore di MYR 22.89M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 10.1 anni e 6.3 anni.

Informazioni chiave

Kirk Kee

Amministratore delegato

RM 283.3k

Compenso totale

Percentuale dello stipendio del CEO	18.3%
Mandato del CEO	14.3yrs
Proprietà del CEO	1.2%
Durata media del management	10.1yrs
Durata media del Consiglio di amministrazione	6.3yrs

Aggiornamenti recenti sulla gestione

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Kirk Kee rispetto agli utili di Apex Healthcare Berhad?
Data	Compenso totale	Stipendio	Guadagni aziendali
Mar 31 2024	n/a	n/a	RM 395m
Dec 31 2023	RM 283k	RM 52k	RM 398m
Sep 30 2023	n/a	n/a	RM 413m
Jun 30 2023	n/a	n/a	RM 415m
Mar 31 2023	n/a	n/a	RM 109m
Dec 31 2022	RM 321k	RM 51k	RM 101m
Sep 30 2022	n/a	n/a	RM 87m
Jun 30 2022	n/a	n/a	RM 74m
Mar 31 2022	n/a	n/a	RM 63m
Dec 31 2021	RM 289k	RM 57k	RM 59m
Sep 30 2021	n/a	n/a	RM 53m
Jun 30 2021	n/a	n/a	RM 53m
Mar 31 2021	n/a	n/a	RM 54m
Dec 31 2020	RM 367k	RM 101k	RM 56m
Sep 30 2020	n/a	n/a	RM 56m
Jun 30 2020	n/a	n/a	RM 56m
Mar 31 2020	n/a	n/a	RM 56m
Dec 31 2019	RM 341k	RM 99k	RM 53m
Sep 30 2019	n/a	n/a	RM 56m
Jun 30 2019	n/a	n/a	RM 56m
Mar 31 2019	n/a	n/a	RM 57m
Dec 31 2018	RM 539k	RM 100k	RM 59m
Sep 30 2018	n/a	n/a	RM 55m
Jun 30 2018	n/a	n/a	RM 51m
Mar 31 2018	n/a	n/a	RM 48m
Dec 31 2017	RM 366k	RM 105k	RM 44m

Compensazione vs Mercato: La retribuzione totale di Kirk ($USD 64.68K ) è inferiore alla media delle aziende di dimensioni simili nel mercato MY ($USD 193.35K ).

Compensazione vs guadagni: La retribuzione di Kirk è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Kirk Kee (62 yo)

14.3yrs

Mandato

RM 283,273

Compensazione

Dr. Kirk Chin Kee has been the Chief Executive Officer and Chairman of Apex Healthcare Berhad since May 19, 2010 and served as its Managing Director since March 3, 2000. He has been Executive Director of A...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Kirk Kee	Chairman & CEO	14.3yrs	RM 283.27k	1.17% MYR 22.9m
Woon Chiew	CFO & Joint Company Secretary	10.1yrs	Nessun dato	Nessun dato
Hing Tan	Chief Operating Officer of Distribution Group	2.4yrs	Nessun dato	Nessun dato
Kien Ch'ng	Chief Operating Officer of Manufacturing Group	9.6yrs	Nessun dato	Nessun dato
Yoke Chan	Joint Company Secretary	10.5yrs	Nessun dato	Nessun dato

10.1yrs

Durata media

60yo

Età media

Gestione esperta: Il team dirigenziale di AHEALTH è esperto e expertise (durata media dell'incarico 10.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Kirk Kee	Chairman & CEO	24.5yrs	RM 283.27k	1.17% MYR 22.9m
Robert Millner	Non-Independent Non-Executive Director	24.5yrs	RM 60.14k	0.061% MYR 1.2m
Khai Leong	Independent Non-Executive Director	3yrs	RM 102.00k	0.23% MYR 4.5m
Kirk Kee	Non-Independent Non-Executive Director	8.3yrs	RM 85.00k	Nessun dato
Ah Phang	Independent Non-Executive Director	6.3yrs	RM 102.00k	0.0021% MYR 40.9k
Seng Yap	Independent & Non Executive Director	1.3yrs	RM 69.84k	Nessun dato
Wat Le	Independent & Non-Executive Director	1.3yrs	RM 56.10k	0.0042% MYR 81.6k

6.3yrs

Durata media

63yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di AHEALTH sono considerati esperti (durata media dell'incarico 6.3 anni).

Apex Healthcare Berhad Gestione

Gestione criteri di controllo 4/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Recent updates

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

New 90-day high: RM3.78

Apex Healthcare Berhad to Be Deleted from Other OTC

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Third quarter 2020 earnings released: EPS RM0.03

Upcoming Dividend of RM0.017 Per Share

Price target raised to RM2.60

First half earnings released